Skip to main content

Mirtazapine News

FDA Medwatch Alert: Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Mirtazapine Tablets Lot Number 03119002A3 Due to Label Error on Declared Strength

December 31, 2019 – Aurobindo Pharma USA, Inc. is voluntarily recalling lot number 03119002A3 of Mirtazapine Tablets to the consumer level. The product is being recalled due to a label error on...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Insomnia, Anxiety, Depression, Hot Flashes, Major Depressive Disorder, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder

Related drug support groups

Remeron

Mirtazapine patient information at Drugs.com